← Back
$LENZ All transactions

LENZ Therapeutics, Inc.

A

$ Value

$0

Shares

358,100

Price

$0

Filed

Jan 6

Insider

Name

Schimmelpennink Evert B.

Title

President, CEO and Secretary

CIK

0001713795

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

358,100

Footnotes

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean January 2, 2026.

Filing Info

Accession No.

0001713795-26-000002

Form Type

4

Issuer CIK

0001815776

Schimmelpennink Evert B.'s History

Date Ticker Type Value
2026-03-27 LENZ $251K
2026-01-02 LENZ A $0
2025-11-20 IBIO A $0
2025-06-26 CTNM A $0

Other Insiders at LENZ (90d)

Insider Bought Sold Last
Schimmelpennink Evert B.
President, CEO and Secretary
$251K 2026-03-27
Chevallard Daniel R.
Chief Financial Officer
$64K 2026-03-27
George Jeffrey P. $50K 2026-03-27